CA
NZ
UK
AU
IND
US
Broker BofA initiated coverage on WFRD with a ‘buy’ rating, while highlighting that the stock has the potential for a ‘strong turnaround’ in margins. The consensus mean price target on WFRD is US$ 121, and the mean recommendation rating on the stock is 1.
Broker D.A. Davidson raised its rating on Booking Holdings from 'neutral' to 'buy'. After the increase, BKNG’s share price surged 5% on September 26, 2023.
Broker KeyBanc raised its rating on Uber, based on the positive prospects it sees for the company. KeyBanc expects Uber’s expense discipline to help increase EBITDA and free cash flow.
Automobile companies Ford and General Motors received a rating upgrade from broker Barclays. Both the stocks were upgraded to an 'overweight' rating.
Eyenovia bagged an ‘outperform’ rating from Wiliam Blair as the broker expects increased ophthalmic therapy deliveries for the company.
Broker Wells Fargo raised its rating and price target on Gap Inc. The positive sentiment on the stock is largely based on the company’s turnaround story.
Broker Citigroup raised its rating on gene therapy firm Editas Medicine. The consensus mean price target on EDIT is US$13.60, and the mean recommendation rating on the stock is 2.4 on five.
Brokers Raymond James and Wells Fargo raised their ratings on construction company Dycom. The consensus mean price target on DY is US$ 125.22, and the mean recommendation rating on the stock is 1.8 on five.
Broker Morgan Stanley raised its rating on Array Technologies and Hannon Armstrong, based on its positive view of the clean technology sector. Morgan Stanley also raised its price target on First Solar from US$214 to US$226.
Broker Stifel upgraded its rating on toothpaste-maker Colgate from ‘hold to ‘buy’. The consensus mean price target on CL is US$81.94 and the mean recommendation rating stands at 2.4.
Please wait processing your request...